Mirum Pharmaceuticals Inc (MIRM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 49,419 | 28,003 | 35,759 | 55,268 | 46,272 |
| Marketable Securities | 82,654 | 123,716 | 149,588 | 69,685 | 93,636 |
| Receivables | 24,661 | 23,994 | 16,337 | 13,990 | 7,872 |
| Inventories | 6,613 | 5,565 | 6,943 | 4,524 | 1,580 |
| TOTAL | $172,334 | $190,225 | $215,556 | $147,245 | $155,268 |
| Non-Current Assets | |||||
| PPE Net | 877 | 914 | 795 | 832 | 898 |
| Intangibles | 57,695 | 58,954 | 45,032 | 46,072 | 18,481 |
| Other Non-Current Assets | 102,624 | 102,813 | 102,964 | 103,084 | 103,501 |
| TOTAL | $161,196 | $162,681 | $148,791 | $149,988 | $122,880 |
| Total Assets | $333,530 | $352,906 | $364,347 | $297,233 | $278,148 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,440 | 8,690 | 10,548 | 8,119 | 4,943 |
| Accrued Expenses | 40,399 | 54,018 | 38,311 | 34,539 | 26,883 |
| Other current liabilities | 1,090 | 1,090 | 1,764 | 1,764 | 1,996 |
| TOTAL | $48,843 | $64,729 | $51,398 | $45,174 | $34,553 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 143,537 | 146,140 | 143,652 | 141,372 | 134,663 |
| TOTAL | $143,537 | $146,140 | $143,652 | $141,372 | $134,663 |
| Total Liabilities | $192,380 | $210,869 | $195,050 | $186,546 | $169,216 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 38,032 | 37,951 | 36,870 | 32,752 | 31,835 |
| Common Shares | 4 | 4 | 4 | 3 | 3 |
| Retained earnings | -422,954 | -392,824 | -356,393 | -320,687 | -293,765 |
| Other shareholders' equity | 136 | -217 | -413 | -202 | -131 |
| TOTAL | $141,150 | $142,037 | $169,297 | $110,687 | $108,932 |
| Total Liabilities And Equity | $333,530 | $352,906 | $364,347 | $297,233 | $278,148 |